The FDA-approved imaging agent for detecting coronary artery disease gained Medicare and Medicaid coverage starting April 1.

GE HealthCare is also using ACC 2025 to highlight new AI-powered innovations for cardiac care: The latest version of CASE (Cardiac Assessment System for Stress Testing), powered by the company’s ...

We recently published a list of Was Jim Cramer Right About These 13 Stocks? In this article, we are going to take a look at ...

GE Aerospace’s strong Q1 performance and restructuring set it up for long-term growth. Learn why GE stock is a solid buy ...

GE HealthCare Technologies Inc. GEHC recently announced the U.S. launch of Flyrcado (flurpiridaz F 18) injection at the ongoing American College of Cardiology (ACC) Annual Scientific Session & Expo.

We recently published a list of Top 9 AI Ratings and News Updates on Wall Street’s Radar. In this article, we are going to ...

River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 investor letter. A copy of the letter can be downloaded here.

CHICAGO, March 20, 2025--GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial ...

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring ...

Credit: Getty Images / Krisada tepkulmanont / Mashable composite AI is making significant strides in every aspect of our lives, including healthcare. Yet there’s a catch: resource limitations ...

More Bonds of GE Healthcare Technologies Inc. About the GE Healthcare Technologies Inc.-Bond (US36267VAE39) The GE Healthcare Technologies Inc.-Bond has a maturity date of 11/15/2027 and offers a ...